For: | Sivakumar M, Powell LW. Management of human factors engineering-associated hemochromatosis: A 2015 update. World J Hepatol 2016; 8(8): 395-400 [PMID: 27004087 DOI: 10.4254/wjh.v8.i8.395] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i8/395.htm |
Number | Citing Articles |
1 |
Angeliki Katsarou, Kostas Pantopoulos. Hepcidin Therapeutics. Pharmaceuticals 2018; 11(4): 127 doi: 10.3390/ph11040127
|
2 |
Kostas Pantopoulos. Inherited Disorders of Iron Overload. Frontiers in Nutrition 2018; 5 doi: 10.3389/fnut.2018.00103
|
3 |
Giada Sebastiani, Nicole Wilkinson, Kostas Pantopoulos. Pharmacological Targeting of the Hepcidin/Ferroportin Axis. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00160
|
4 |
Sushmita Khadka, Lubomir Sokol. Non-Neoplastic Hematologic Disorders. 2024; : 305 doi: 10.1007/978-3-031-62373-8_23
|
5 |
Michela Asperti, Andrea Denardo, Magdalena Gryzik, Paolo Arosio, Maura Poli. Iron Metabolism: Hepcidin. Vitamins and Hormones 2019; 110: 157 doi: 10.1016/bs.vh.2019.01.008
|